A recent WebMD article discussed a nationwide thyroid drug recall linked to incorrect information on the label. The drug in question is Acella Pharmaceuticals’ NP Thyroid medication intended to treat hypothyroidism. During routine testing, the affected lots were found to contain less than 90% of the two ingredients listed on the label: liothyronine and levothyroxine.
Incorrect Label Potency Leads to Thyroid Drug Recall
Acella Pharmaceuticals has recalled its thyroid medication for the third time in a year over potency issues.
May 14, 2021
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
